Home › NDC Lookup › RxCUI directory › RxCUI 308429

Atovaquone 150 MG/ML Oral Suspension — RxCUI 308429

RxNorm drug concept · Semantic clinical drug
RxCUI 308429 Semantic clinical drug · SCD ● Current RxNorm concept 25 FDA products 33 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI308429
Official nameAtovaquone 150 MG/ML Oral Suspension
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asatovaquone 750 MG per 5 ML Oral Suspension; atovaquone 750 MG in 5 mL Oral Suspension; atovaquone 1500 MG per 10 ML Oral Suspension
FDA products mapped25
Package NDCs mapped33
Reported Medicaid activity (SDUD)24,487 prescriptions · 45 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Atovaquone: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Yes, it really matters — this is one of the most important things to know about atovaquone. Without food, your body absorbs roughly half as much of the medicine, which can mean blo...
  • Why do I have to take this medicine with food? Is it really that important?
  • PCP (Pneumocystis jirovecii pneumonia) is a serious lung infection caused by a fungal organism. It mainly affects people with weakened immune systems, such as those with HIV/AIDS....
  • What is PCP, and why am I being prescribed this instead of a more common antibiotic?
📖 Read our full Atovaquone guide →

🕸️ Concept Web — How Atovaquone 150 MG/ML Oral Suspension Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Atovaquone 150 MG/ML Oral Suspension RxCUI 308429

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Atovaquone 60212
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Mepron 114972
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Atovaquone Oral Suspension 370622
    • Atovaquone Oral Liquid Product 1154385
    • Atovaquone Oral Product 1154386
    • Atovaquone Oral Suspension [Mepron] 365987
    • Mepron Oral Liquid Product 1184392
    • Mepron Oral Product 1184393
    • Oral Suspension 316969
    • Oral Liquid Product 1151137
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Atovaquone 150 MG/ML SCDC · 315439
  • Atovaquone Oral Suspension SCDF · 370622
  • Atovaquone Oral Liquid Product SCDG · 1154385
  • Atovaquone Oral Product SCDG · 1154386

Brand-Name Concepts

  • Atovaquone 150 MG/ML Oral Suspension [Mepron] SBD · 211947
  • Atovaquone 150 MG/ML [Mepron] SBDC · 572274
  • Atovaquone Oral Suspension [Mepron] SBDF · 365987
  • Mepron Oral Liquid Product SBDG · 1184392
  • Mepron Oral Product SBDG · 1184393
  • Mepron BN · 114972

📦 FDA Products & Package NDCs

25 products · 33 package NDCs
33 package NDCs map to RxCUI 308429 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00121-0956-08 1 BOTTLE in 1 CARTON (0121-0956-08) / 210 mL in 1 BOTTLE Atovaquone PAI Holdings, LLC dba PAI Pharma 2025-04-04
00121-1016-18 3 TRAY in 1 CASE (0121-1016-18) / 6 CUP, UNIT-DOSE in 1 TRA... Atovaquone PAI Holdings, LLC dba PAI Pharma 2024-01-10
00121-1016-42 7 TRAY in 1 CASE (0121-1016-42) / 6 CUP, UNIT-DOSE in 1 TRA... Atovaquone PAI Holdings, LLC dba PAI Pharma 2024-01-10
00173-0547-00 42 POUCH in 1 DOSE PACK (0173-0547-00) / 5 mL in 1 POUCH MEPRON GlaxoSmithKline LLC 1998-09-18
00173-0665-18 210 mL in 1 BOTTLE (0173-0665-18) MEPRON GlaxoSmithKline LLC 1995-02-28
00904-7459-25 3 TRAY in 1 CASE (0904-7459-25) / 6 CUP, UNIT-DOSE in 1 TRA... ATOVAQUONE Major Pharmaceuticals 2024-07-08
00904-7459-53 7 TRAY in 1 CASE (0904-7459-53) / 6 CUP, UNIT-DOSE in 1 TRA... ATOVAQUONE Major Pharmaceuticals 2024-07-08
10702-0223-21 1 BOTTLE, PLASTIC in 1 CARTON (10702-223-21) / 210 mL in 1... Atovaquone Oral Suspension KVK-Tech, Inc. 2019-03-29
17856-0631-01 72 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-0631-1) / 5 mL... Atovaquone ATLANTIC BIOLOGICALS CORP. 2024-09-04
17856-8631-01 50 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-8631-1) / 5 mL... Atovaquone ATLANTIC BIOLOGICALS CORP. 2025-10-01
31722-0629-21 1 BOTTLE in 1 CARTON (31722-629-21) / 210 mL in 1 BOTTLE Atovaquone Camber Pharmaceuticals, Inc. 2018-10-11
42239-0001-08 1 BOTTLE in 1 CARTON (42239-001-08) / 210 mL in 1 BOTTLE Atovaquone Abon Pharmaceuticals, LLC 2023-11-14
42239-0001-66 6 CUP, UNIT-DOSE in 1 TRAY (42239-001-66) / 5 mL in 1 CUP,... Atovaquone Abon Pharmaceuticals, LLC 2025-05-01
50268-0119-12 20 CUP in 1 BOX (50268-119-12) / 5 mL in 1 CUP (50268-119-1... ATOVAQUONE AvPAK 2025-10-14
51407-0642-87 1 BOTTLE in 1 CARTON (51407-642-87) / 210 mL in 1 BOTTLE Atovaquone Golden State Medical Supply, Inc. 2022-03-14
60687-0534-36 2 TRAY in 1 CASE (60687-534-36) / 10 CUP, UNIT-DOSE in 1 TR... Atovaquone American Health Packaging 2023-07-13
60687-0534-78 7 TRAY in 1 CASE (60687-534-78) / 6 CUP, UNIT-DOSE in 1 TRA... Atovaquone American Health Packaging 2020-10-21
62135-0528-09 210 mL in 1 BOTTLE (62135-528-09) Atovaquone Chartwell RX, LLC 2023-07-18
62135-0528-24 2 TRAY in 1 BOX (62135-528-24) / 10 CUP in 1 TRAY / 5 mL in... Atovaquone Chartwell RX, LLC 2024-05-23
65162-0693-88 1 BOTTLE in 1 CARTON (65162-693-88) / 210 mL in 1 BOTTLE ATOVAQUONE Amneal Pharmaceuticals LLC 2011-02-09
68462-0421-21 210 mL in 1 BOTTLE (68462-421-21) atovaquone Glenmark Pharmaceuticals Inc., USA 2017-12-31
68462-0421-69 42 POUCH in 1 CARTON (68462-421-69) / 5 mL in 1 POUCH atovaquone Glenmark Pharmaceuticals Inc., USA 2017-12-31
68999-0528-24 2 TRAY in 1 BOX (68999-528-24) / 10 CUP in 1 TRAY / 5 mL in... Atovaquone Chartwell Governmental & Specialty RX, LLC. 2025-10-25
69452-0252-87 1 BOTTLE in 1 CARTON (69452-252-87) / 210 mL in 1 BOTTLE Atovaquone Bionpharma Inc. 2021-06-01
70748-0299-01 1 BOTTLE in 1 CARTON (70748-299-01) / 210 mL in 1 BOTTLE ATOVAQUONE Lupin Pharmaceuticals, Inc. 2021-06-01
72603-0248-01 1 BOTTLE in 1 CARTON (72603-248-01) / 210 mL in 1 BOTTLE Atovaquone NorthStar RxLLC 2024-05-01
73141-0104-42 42 CUP, UNIT-DOSE in 1 CARTON (73141-104-42) / 5 mL in 1 CU... Atovaquone A2A Integrated Pharmaceuticals, LLC 2024-11-29
73190-0098-21 1 BOTTLE in 1 CARTON (73190-098-21) / 210 mL in 1 BOTTLE ATOVAQUONE AvKARE 2026-06-14
81033-0104-22 20 CUP, UNIT-DOSE in 1 CARTON (81033-104-22) / 5 mL in 1 CU... Atovaquone Kesin Pharma 2025-09-15
81033-0104-42 42 CUP, UNIT-DOSE in 1 CARTON (81033-104-42) / 5 mL in 1 CU... Atovaquone Kesin Pharma 2024-06-17
81033-0104-50 50 CUP, UNIT-DOSE in 1 CARTON (81033-104-50) / 5 mL in 1 CU... Atovaquone Kesin Pharma 2024-06-17
81033-0105-22 20 CUP, UNIT-DOSE in 1 CARTON (81033-105-22) / 5 mL in 1 CU... Atovaquone Oral Suspension Kesin Pharma Corporation 2026-02-06
81033-0105-42 42 CUP, UNIT-DOSE in 1 CARTON (81033-105-42) / 5 mL in 1 CU... Atovaquone Oral Suspension Kesin Pharma Corporation 2026-02-06
Observed labelers: Kesin Pharma (3) · PAI Holdings, LLC dba PAI Pharma (3) · Abon Pharmaceuticals, LLC (2) · American Health Packaging (2) · ATLANTIC BIOLOGICALS CORP. (2) · Chartwell RX, LLC (2) · +16 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$0.7030
Range $0.7030–$0.7185 · middle 50% $0.7030–$0.7030 · 15 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.